Post-translational regulation of the tumor suppressor p27(KIP1).
Mitogenic signals stimulate cell division by activating cyclin/cyclin-dependent kinase (CDK) complexes. Their timely regulation ensures proper cell cycle progression. It is therefore not surprising that cyclin/CDK complexes are integrators of multiple signals from both the extracellular environment and intracellular cues. Important regulators of cyclin/CDKs are the CDK inhibitors that have attracted attention due to their association with disease. p27(KIP1) is a CDK inhibitor that controls CDK activity throughout the cell cycle. As a CDK inhibitor, p27(KIP1) has tumor suppressor activity. Besides CDKs, p27(KIP1) regulates additional cellular processes, including cell motility, some of which seem to mediate oncogenic activities of p27(KIP1). These activities of p27(KIP1) are regulated through multiple phosphorylation sites, targeted by several signal transduction pathways. Understanding functions and regulation of p27(KIP1) will be important to determine which isoform of p27(KIP1) has anti- or pro-tumorigenic activities. Such knowledge might be of prognostic value and may offer novel therapeutic windows.
Vervoorts
J
J
Institute of Biochemistry, Medical School, RWTH Aachen University, Pauwelsstrasse 30, 52057, Aachen, Germany. jvervoorts-weber@ukaachen.de
Lüscher
B
B
D000818:Animals; D002453:Cell Cycle / Q000187:drug effects; D050760:Cyclin-Dependent Kinase Inhibitor p27 / Q000378:metabolism*; D003593:Cytoplasm / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D008934:Mitogens / Q000494:pharmacology; D009369:Neoplasms / Q000378:metabolism / Q000473:pathology; D011499:Protein Processing, Post-Translational / Q000187:drug effects
D008934:Mitogens; D050760:Cyclin-Dependent Kinase Inhibitor p27